Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients

This publication has 31 references indexed in Scilit:

• High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patients
  Kidney International, 1996
• A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes
  Published by American Medical Association (AMA) ,1995
• Net uptake of plasma homocysteine by the rat kidney in vivo
  Atherosclerosis, 1995
• A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase
  Nature Genetics, 1995
• Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study
  Atherosclerosis, 1995
• Mechanism of erythrocyte accumulation of methylation inhibitor S-adenosylhomocysteine in uremia
  Kidney International, 1995
• Vitamin status and intake as primary determinants of homocysteinemia in an elderly population
  JAMA, 1993
• Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
  JAMA, 1993
• Cross-sectional Assessment of Weekly Urea and Creatinine Clearances in Patients on Continuous Ambulatory Peritoneal Dialysis
  Asaio Journal, 1992
• Sulphur containing amino acids in chronic renal failure with particular reference to homocystine and cysteine‐homocysteine mixed disulphide
  European Journal of Clinical Investigation, 1979